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This project was done in order to measure the stability of proteins in general; in particular 
C-Reactive Protein (CRP) which is very important in cardiovascular studies. Current 
methods of handling CRP is to freeze the sample at -80°C for long term use, or -20°C for 
medium term use, or 4°C for short term use. This experiment was done in order to 
measure how much CRP will degrade after a certain time with different matrices. From 
this project, no conclusive data was gathered to give a certain approximation on the 
stability of CRP. The data that was gathered did tell us that CRP is most stable with PBS 
with 0.5% Albumin (PBSA) than saliva, which is more stable than in nanopure water. 
Furthermore, the data showed that samples kept at -20°C were more stable than those 



















































 Cardiovascular disease is one of the most prominent cause of death in the United 
States. Finding an early detection method would prove to be a useful way to diagnose a 
patient and to improve the patient’s health. As such, C-Reactive Protein (CRP) have been 
seen to increase when there is tissue damage. Concentration of serum proteins, such as 
CRP, increase before a major heart attack. This increase in CRP has been caused from the 
atherosclerosis (major clotting of the heart). As such, diagnosis of increased levels of 
CRP can help prevent major onset of cardiovascular disease.  
  
C-REACTIVE PROTEIN (CRP) 
  
 C-Reactive Protein (CRP) has been discovered by Tillett and Francis1, and 
Abernethy and Avery1 in 19032. It was found that this protein bound to C-polysaccharide 
on the cell wall of Streptococcus pneumonia1 As such, it has been called C-Reactive 
Protein due to this reaction where upon binding to Streptococcus pneumonia, the 
complement cascade is activated2. CRP has been showed to bind to phosphocholine2 
which are lipids found within the cell membrane. The following is a figure that represents 




Figure 1: Structure of C-Reactive Protein (Protein Data Bank, structure ID 1b09) 
 
CRP has been characterized as being cyclic and composed of five identical noncovalently 
subunits that are bound to make up the protein1 with a molecular weight of 118,000 
Daltons1. 
 
CRP is synthesized within liver cells (hepatocytes), where it is secreted in the presence of 
interleukin-61. Within humans, it has been shown that there is an increase in the levels of 
serum CRP within 1 to 2 days after major tissue damage1. CRP studies have found that 
increased levels of CRP leads to atherogenesis3,5. It has been reported by Fiedel and 
Gewurz that platelet aggregation occurs due to CRP concentration increase in serum1.  
 
C-Reactive Protein has been shown to increase when there is a site of inflammation, up 
regulated during myocardial infarction, diabetes, and acute and chronic hypertension1. 
There is a direct relationship between the high incidence LDL cholesterol and the 
increase of serum CRP levels. This can be seen in the following figure: 
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Figure 2: Increase level of myocardial infarction is strongly directly related to serum CRP proteins 
and weakly directly related to LDL8 
 
Individuals with increased CRP levels have been seen to have a higher risk of deaths 
related to cardiovascular disease8. Furthermore, CRP has been shown to be a better 




Figure 3: Serum CRP as a better indicator of mortality rate related to cardiovascular disease than 
LDL concentration8 
 
Average serum concentration of healthy humans has been seen to be less than 2 mg/L1; 
where elevated levels are found to be greater than 3 mg/L1. Stability tests have been done 
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on CRP and have been found that CRP has been stable at 4° and 21°C for 5 days and 
stable at 30°C for 2 days4 and have a half life of 19 hours in serum.  
 
ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 
 
 This is a type of technique that is developed in order to measure proteins using 
antibodies that can fluorescence. An antibody is attached to the polystyrene of the 96 
plate well that binds well to CRP. The sample is added so that the CRP, and only CRP 
binds, to the antibody that is attached to the polystyrene.  
 
Figure 4: Summary of ELISA (http://64.202.120.86/upload/image/articles/2006/biopen/biopen-elisa-
schematic.jpg) 
 
After several washes to remove the excess sample, a secondary antibody is added. This 
secondary antibody has an enzyme that will catalytically convert a substrate so that the 
product can fluoresce. As such, when the secondary antibody is added to the well, it will 
bind to the CRP that is already bound to the primary antibody on the polystyrene. A 
substrate is added into each well so that the enzyme that is covalently linked to the 
secondary antibody will convert the substrate into a product that can fluoresce. This 








 ALPCO EIA Kits for C-Reactive Protein (hsCRP) 





Samples for Time Decay of CRP: 
 Un-stimulated saliva was taken and used as a matrix 
 1 mL of Saliva with 100 ng/mL of CRP was added to each sample 
 Variations from using 0.5% PBS with Albumin (PBSA) as a diluent and water 
were done when diluting CRP 
 3 day and 2 day storage of the samples at both 4°C and -20°C 
Samples for Freeze Thaw of CRP: 
 100 ng/mL of CRP in 1 mL of matrix 
• Matrix consisted of either water, PBSA, or saliva 
 Flash freeze thaw cycles of 5, 4, 3, 2, 1 times were done in which each cycle 
consisting of 10 minutes at -80°C and 10 minutes at 25°C 
ELISA: 































From the ELISA plate, the following table is the CRP concentration reading in ng/mL: 





3 day    
4°C 13.80 -3.14 -8.49 
-20°C 28.83 23.60 -8.07 
2 day      
4°C 12.30 -0.64 x 
-20°C 8.28 21.69 x 
    
[CRP] (ng/mL) PBSA H2O Saliva 
Freeze Thaw 1 126.85 -8.05 55.01 
Freeze Thaw 2 53.89 0.18 31.60 
Freeze Thaw 3 106.85 -4.88 33.80 
Freeze Thaw 4 117.89 -3.11 39.39 
Freeze Thaw 5 141.11 -6.20 27.37 
 
This ELISA plate is giving readings that are not supposed to be there. This is because the 
highest concentration should be no more than 100 ng/mL (the initial spike) and no less 
than 0 ng/mL.  Even from these major deviations, one can see that PBSA (0.5% PBS with 
Albumin) is a better choice as a matrix to use to store samples when compared to water 
as the matrix. Furthermore, pure saliva was better than water, but not better than PBSA. 
This would suggest that the concentration of proteins found within the saliva is lower 
than that found within 0.5% PBS with Albumin (PBSA). Furthermore, using -20°C 
would degrade the samples less than if kept at 4°C.  
FUTURE STUDIES 
This experiment has to be redone. This experiment was supposed to be done in 
sync with the Luminex instrument, but other factors inhibited that study to be done. As 
such, in the future, Luminex should be taken into account for better results. Futhermore, 
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Figure 5: Picture of CRP ELISA Plate 
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OD Values         
0.2274 0.0644 0.1374 0.0801 0.1914 1.2002 0.0217 0.0981 0.4587
0.1825 0.2221 0.1978 0.2564 0.2706 0.9268 -0.008 -0.0083 0.3284
-0.0096 0.3326 0.0202 0.3205 -0.0116 0.9043 0.0505 -0.0077 0.3107
0.0096 0.8452 0.0426 0.0484 -0.0082 0.948 0.0129 0.2981 0.023 
0.3962 0.01 0.1012 0.2464 1.1047 0.0317 0.0271 0.2552 0.5288
-0.0133 1.452 0.2099 0.1709 1.2772 1.2355 0.0078 0.3733 0.469 
0.0236 0.9517 0.0229 0.0756 0.8084 0.9172 0.0181 0.179   
 



















OD value =     slope     * CRP Concentration + intercept 
y = 0.0080383 x + 0.056677 
    
R2 = 0.9568277   
 
[CRP] ng/mL        
21.24 0.96 10.04 2.91 16.76 142.26 -4.35 5.15 50.01
15.65 20.58 17.56 24.85 26.61 108.25 -8.05 -8.08 33.80
-8.25 34.33 -4.54 32.82 -8.49 105.45 -0.77 -8.01 31.60
-5.86 98.10 -1.75 -1.03 -8.07 110.88 -5.45 30.03 -4.19 
42.24 -5.81 5.54 23.60 130.38 -3.11 -3.68 24.70 58.73
-8.71 173.58 19.06 14.21 151.84 146.65 -6.08 39.39 51.29










3 day    
4°C 13.80 -3.14 -8.49 
-20°C 28.83 23.60 -8.07 
2 day      
4°C 12.30 -0.64 x 
-20°C 8.28 21.69 x 
    
[CRP] (ng/mL) PBSA H2O Saliva 
Freeze Thaw 1 126.85 -8.05 55.01 
Freeze Thaw 2 53.89 0.18 31.60 
Freeze Thaw 3 106.85 -4.88 33.80 
Freeze Thaw 4 117.89 -3.11 39.39 
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